Matthew J Price1, David Slotwiner2, Chengan Du3, James V Freeman4, Zoltan Turi5, Chidambaram Rammohan6, Fred M Kusumoto7, Clifford Kavinsky8, Joseph Akar4, Paul D Varosy9, Christina Koutras10, Jeptha P Curtis11, Frederick A Masoudi12. 1. Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California, USA. Electronic address: price.matthew@scrippshealth.org. 2. Division of Cardiology, New York Presbyterian Queens, Weill Cornell Medical College, New York, New York, USA. 3. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, USA. 4. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. 5. Center for Structural and Congenital Heart Disease, Hackensack University Medical Center, Hackensack, New Jersey, USA. 6. Division of Cardiovascular Medicine, Palo Alto Medical Foundation, El Camino Hospital, Mountain View, California. 7. Department of Cardiovascular Disease, Mayo Clinic, Jacksonville, Florida, USA. 8. Division of Cardiovascular Medicine, Rush University Medical Center, Chicago, Illinois, USA. 9. VA Eastern Colorado Health Care System and University of Colorado, Aurora, Colorado, USA. 10. American College of Cardiology Foundation, Washington, District of Columbia, USA. 11. Division of Cardiology, New York Presbyterian Queens, Weill Cornell Medical College, New York, New York, USA; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, USA. 12. Ascension Health, St. Louis, Missouri, USA.
Abstract
OBJECTIVES: The aim of this study was to report 1-year clinical outcomes following commercial transcatheter left atrial appendage occlusion (LAAO) in the United States. BACKGROUND: The National Cardiovascular Data Registry LAAO Registry was initiated to meet a condition of Medicare coverage and allow the assessment of clinical outcomes. The 1-year rates of thromboembolic events after transcatheter LAAO in such a large cohort of "real-world" patients have not been previously reported. METHODS: Patients entered into the National Cardiovascular Data Registry LAAO Registry for a Watchman procedure between January 1, 2016, and December 31, 2018, were included. The primary endpoint was ischemic stroke. Key secondary endpoints included the rate of ischemic stroke or systemic embolism, mortality, and major bleeding. Major bleeding was defined as any bleeding requiring hospitalization, and/or causing a decrease in hemoglobin level > 2g/dL, and/or requiring blood transfusion that was not hemorrhagic stroke. The Kaplan-Meier method was used for 1-year estimates of cumulative event rates. RESULTS: The study population consisted of 36,681 patients. The mean age was 76.0 ± 8.1 years, the mean CHA2DS2-VASc score was 4.8 ± 1.5, and the mean HAS-BLED score was 3.0 ± 1.1. Prior stroke was present in 25.5%, clinically relevant bleeding in 69.5%, and intracranial bleeding in 11.9%. Median follow-up was 374 days (IQR: 212-425 days). The Kaplan-Meier-estimated 1-year rate of ischemic stroke was 1.53% (95% CI: 1.39%-1.69%), the rate of ischemic stroke or systemic embolism was 2.19% (95% CI: 2.01%-2.38%), and the rate of mortality was 8.52% (95% CI: 8.19%-8.87%). The 1-year estimated rate of major bleeding was 6.93% (95% CI: 6.65%-7.21%). Most bleeding events occurred between discharge and 45 days following the procedure. CONCLUSIONS: This study characterizes important outcomes in a national cohort of patients undergoing transcatheter LAAO in the United States. Clinicians and patients can integrate these data in shared decision making when considering this therapy.
OBJECTIVES: The aim of this study was to report 1-year clinical outcomes following commercial transcatheter left atrial appendage occlusion (LAAO) in the United States. BACKGROUND: The National Cardiovascular Data Registry LAAO Registry was initiated to meet a condition of Medicare coverage and allow the assessment of clinical outcomes. The 1-year rates of thromboembolic events after transcatheter LAAO in such a large cohort of "real-world" patients have not been previously reported. METHODS: Patients entered into the National Cardiovascular Data Registry LAAO Registry for a Watchman procedure between January 1, 2016, and December 31, 2018, were included. The primary endpoint was ischemic stroke. Key secondary endpoints included the rate of ischemic stroke or systemic embolism, mortality, and major bleeding. Major bleeding was defined as any bleeding requiring hospitalization, and/or causing a decrease in hemoglobin level > 2g/dL, and/or requiring blood transfusion that was not hemorrhagic stroke. The Kaplan-Meier method was used for 1-year estimates of cumulative event rates. RESULTS: The study population consisted of 36,681 patients. The mean age was 76.0 ± 8.1 years, the mean CHA2DS2-VASc score was 4.8 ± 1.5, and the mean HAS-BLED score was 3.0 ± 1.1. Prior stroke was present in 25.5%, clinically relevant bleeding in 69.5%, and intracranial bleeding in 11.9%. Median follow-up was 374 days (IQR: 212-425 days). The Kaplan-Meier-estimated 1-year rate of ischemic stroke was 1.53% (95% CI: 1.39%-1.69%), the rate of ischemic stroke or systemic embolism was 2.19% (95% CI: 2.01%-2.38%), and the rate of mortality was 8.52% (95% CI: 8.19%-8.87%). The 1-year estimated rate of major bleeding was 6.93% (95% CI: 6.65%-7.21%). Most bleeding events occurred between discharge and 45 days following the procedure. CONCLUSIONS: This study characterizes important outcomes in a national cohort of patients undergoing transcatheter LAAO in the United States. Clinicians and patients can integrate these data in shared decision making when considering this therapy.
Authors: Patricia O Guimarães; Arun Krishnamoorthy; Lisa A Kaltenbach; Kevin J Anstrom; Mark B Effron; Daniel B Mark; Patrick L McCollam; Linda Davidson-Ray; Eric D Peterson; Tracy Y Wang Journal: JAMA Cardiol Date: 2017-07-01 Impact factor: 14.676
Authors: David R Holmes; Vivek Y Reddy; Nicole T Gordon; David Delurgio; Shephal K Doshi; Amish J Desai; James E Stone; Saibal Kar Journal: J Am Coll Cardiol Date: 2019-12-10 Impact factor: 24.094
Authors: Saibal Kar; Shephal K Doshi; Ashish Sadhu; Rodney Horton; Jose Osorio; Christopher Ellis; James Stone; Manish Shah; Srinivas R Dukkipati; Stuart Adler; Devi G Nair; Jamie Kim; Oussama Wazni; Mathew J Price; Federico M Asch; David R Holmes; Robert D Shipley; Nicole T Gordon; Dominic J Allocco; Vivek Y Reddy Journal: Circulation Date: 2021-04-06 Impact factor: 29.690
Authors: Muhammad R Afzal; James K Gabriels; Gregory G Jackson; Lu Chen; Benjamin Buck; Sandra Campbell; Dawn F Sabin; Bruce Goldner; Haisam Ismail; Christopher F Liu; Apoor Patel; Stuart Beldner; Emile G Daoud; John D Hummel; Christopher R Ellis Journal: JACC Clin Electrophysiol Date: 2021-08-25
Authors: Srinivas R Dukkipati; Saibal Kar; David R Holmes; Shephal K Doshi; Vijendra Swarup; Douglas N Gibson; Brijeshwar Maini; Nicole T Gordon; Michael L Main; Vivek Y Reddy Journal: Circulation Date: 2018-08-28 Impact factor: 29.690
Authors: David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy Journal: J Am Coll Cardiol Date: 2014-07-08 Impact factor: 24.094
Authors: David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick Journal: Lancet Date: 2009-08-15 Impact factor: 79.321
Authors: James V Freeman; Paul Varosy; Matthew J Price; David Slotwiner; Fred M Kusumoto; Chidambaram Rammohan; Clifford J Kavinsky; Zoltan G Turi; Joseph Akar; Cristina Koutras; Jeptha P Curtis; Frederick A Masoudi Journal: J Am Coll Cardiol Date: 2020-04-07 Impact factor: 24.094
Authors: Richard P Whitlock; Emilie P Belley-Cote; Domenico Paparella; Jeff S Healey; Katheryn Brady; Mukul Sharma; Wilko Reents; Petr Budera; Andony J Baddour; Petr Fila; P J Devereaux; Alexander Bogachev-Prokophiev; Andreas Boening; Kevin H T Teoh; Georgios I Tagarakis; Mark S Slaughter; Alistair G Royse; Shay McGuinness; Marco Alings; Prakash P Punjabi; C David Mazer; Richard J Folkeringa; Andrea Colli; Álvaro Avezum; Juliet Nakamya; Kumar Balasubramanian; Jessica Vincent; Pierre Voisine; Andre Lamy; Salim Yusuf; Stuart J Connolly Journal: N Engl J Med Date: 2021-05-15 Impact factor: 91.245
Authors: Lucas V A Boersma; Boris Schmidt; Timothy R Betts; Horst Sievert; Corrado Tamburino; Emmanuel Teiger; Evgeny Pokushalov; Stephan Kische; Thomas Schmitz; Kenneth M Stein; Martin W Bergmann Journal: Eur Heart J Date: 2016-01-27 Impact factor: 29.983